• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Aspirin and clopidogrel resistance in Indian patients with ischemic stroke and its associations with gene polymorphisms: A pilot study
Conclusion: Unlike aspirin, a high proportion of nonresponders to clopidogrel was identified. In an interim analysis on 65 Indian patients, a significant association was found between CYP2C19*2 and clopidogrel nonresponsiveness.
Source: Annals of Indian Academy of Neurology - April 8, 2019 Category: Neurology Authors: Samir Patel Vandana Arya Amrita Saraf Manorama Bhargava CS Agrawal Source Type: research

Cost Effectiveness of Genotype-Guided Antiplatelet Therapy in Asian Ischemic Stroke Patients: Ticagrelor as an Alternative to Clopidogrel in Patients with CYP2C19 Loss of Function Mutations
ConclusionThis study suggests that it is cost effective to screen for LOF mutations in the CYP2C19 gene in ischemic stroke populations, with ticagrelor as a substitute for clopidogrel in those with LOF mutations.
Source: Clinical Drug Investigation - September 20, 2020 Category: Drugs & Pharmacology Source Type: research

Short- and Long-Term Follow-up of Antithrombotic Management Patterns in Patients Hospitalized with Acute Coronary Syndrome (ACS): Indian Subgroup of EPICOR-Asia Study
ConclusionThis study showed a gap between international recommendations and implementation for managing ACS in Indian patients.. Most of the patients prefer to undergo invasive management instead of noninvasive therapy.. At the end of 2-year follow up more than half of the population were receiving DAPT, with most patients on receiving a combination of aspirin and clopidogrel The mortality along with composite events of death, MI, or ischemic stroke was highest for NSTEMI patients.
Source: Indian Heart Journal - January 3, 2019 Category: Cardiology Source Type: research

Short- and long-term follow-up of antithrombotic management patterns in patients hospitalized with acute coronary syndrome: Indian subgroup of EPICOR Asia study.
CONCLUSION: This study showed a gap between international recommendations and implementation for managing ACS in Indian patients. Most of the patients prefer to undergo invasive management instead of non-invasive therapy. At the end of the 2-year follow-up, more than half of the population was receiving DAPT, with most patients on receiving a combination of aspirin and clopidogrel. The mortality along with composite events of death, MI, or ischemic stroke was highest for patients with NSTEMI. PMID: 31000179 [PubMed - in process]
Source: Indian Heart J - December 31, 2018 Category: Cardiology Authors: Sawhney JPS, Mullasari A, Kahali D, Mehta V, Nair T, Kaul U, Hirematth MS Tags: Indian Heart J Source Type: research

Efficacy and safety of ticagrelor versus clopidogrel with different dosages in acute coronary syndrome patients with high GRACE and CRUSADE scores
CONCLUSIONS: In PCI patients with a high ischemic and bleeding risk, the ticagrelor antiplatelet strategy significantly reduced the MACCE rate without increasing the risk of major bleeding. A decreased MACCE rate was also observed in patients administered the double dosage of clopidogrel, but the bleeding risk was increased compared with the control group.PMID:34154742 | DOI:10.1016/j.ihj.2021.02.002
Source: Indian Heart J - June 22, 2021 Category: Cardiology Authors: Peng Xiao Feng Xie Yunjing Lan Source Type: research

Pages: 1  2  3  4  5  6  7